Invezz

Ethos Technologies (LIFE)

Nasdaq Market Open

Ethos Technologies Inc. is a life insurance technology company built around a digital, direct-to-consumer distribution model. The company’s platform is designed to make buying life insurance simpler by allowing customers to research coverage, compare policy options, submit applications, and complete much of the underwriting process online. Its Class A common stock gives public-market investors exposure to a business operating at the intersection of insurance distribution, consumer fintech, and data-driven underwriting.

Ethos works with insurance carriers rather than underwriting policies entirely on its own balance sheet. Its technology connects consumers with term and other life insurance products offered by carrier partners, while using data analytics, automated workflows, and online interfaces to reduce friction in the application and policy issuance process. The platform also supports independent agents, giving the company a hybrid model that combines digital customer acquisition with agent-assisted sales where needed.

Revenue is primarily generated from commissions paid by insurance carriers when policies are activated through the Ethos platform. The company also provides third-party administrator services connected to policies sold through its channels, adding another service-based revenue stream. This model ties Ethos’ growth to its ability to attract prospective policyholders, improve conversion rates, maintain carrier relationships, and support efficient policy servicing.

Ethos operates in the large US life insurance market, where many consumers remain underinsured and traditional application processes can be time-consuming. Its distinctive feature is the use of proprietary technology to modernize distribution and underwriting rather than relying solely on legacy broker or agent networks.

16.94 USD
+0.05 (+0.30%)

Last updated

Market Cap
P/E
P/FCF
P/S
Enterprise Value
Sector
Financials
Industry
Insurance Agents, Brokers, and Service
Address
1606 HEADWAY CIRCLE, AUSTIN, TX, 78754
GlobeNewswire Inc.

aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”

Jun 03, 2024, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 24, 2024, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference

May 15, 2024, 07:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

May 14, 2024, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update

May 02, 2024, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma to Participate in April Investor Conferences

Apr 01, 2024, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

Mar 14, 2024, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results

Feb 28, 2024, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

Nov 13, 2023, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update

Nov 09, 2023, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes

Sep 11, 2023, 08:00 AM
Zacks Investment Research

5 Top Stocks to Play Earnings Beat Potential

Sep 04, 2023, 07:30 AM
Zacks Investment Research

Down -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma (LIFE)

Aug 30, 2023, 09:35 AM
GlobeNewswire Inc.

aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 24, 2023, 08:00 AM
Zacks Investment Research

5 Top Stocks Likely to Top Earnings Estimates

Aug 18, 2023, 07:49 AM
Zacks Investment Research

Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates

Aug 09, 2023, 17:30 PM
GlobeNewswire Inc.

aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update

Aug 09, 2023, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference

Jun 20, 2023, 08:00 AM
GlobeNewswire Inc.

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 09, 2023, 16:00 PM
GlobeNewswire Inc.

aTyr Pharma to Present at the 2023 Jefferies Healthcare Conference

May 25, 2023, 08:00 AM

Income Statement

Line Item 2026 Q1
Revenue 193.1M
Gross profit 189.87M
Operating income -163.31M
EBITDA -161.97M
Net income -172.03M
Basic EPS -3.57
Diluted EPS -3.57

Balance Sheet

Line Item 2026 Q1
Total assets 619.36M
Total liabilities 178.04M
Total equity 441.32M
Cash & equivalents 107.91M
Current assets 259.35M
Current liabilities 154.96M

Cash Flow

Line Item 2026 Q1
Operating cash flow 31.21M
Investing cash flow -52.1M
Financing cash flow 37.78M
Change in cash 16.9M
Kind Filing Date Link
edgar index 4 — Ethos Technologies Inc. View Filing
edgar index 4 — Ethos Technologies Inc. View Filing
edgar index 4 — Ethos Technologies Inc. View Filing
edgar index 4 — Ethos Technologies Inc. View Filing
edgar index 4 — Ethos Technologies Inc. View Filing
edgar index SCHEDULE 13G — Ethos Technologies Inc. View Filing
edgar index SCHEDULE 13G — Ethos Technologies Inc. View Filing
edgar index SCHEDULE 13G — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index 144 — Ethos Technologies Inc. View Filing
edgar index SCHEDULE 13G — Ethos Technologies Inc. View Filing
edgar index SCHEDULE 13G — Ethos Technologies Inc. View Filing
form 4 Form 4 — GV 2021 GP, L.L.C. View Filing
form 4 Form 4 — GV 2019 GP, L.L.C. View Filing
form 4 Form 4 — GV 2021 GP, L.P. View Filing
form 4 Form 4 — GV 2021 GP, L.P. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing
form 4 Form 4 — GV 2021 GP, L.P. View Filing
form 4 Form 4 — GV 2021, L.P. View Filing
form 4 Form 4 — GV 2021, L.P. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing
form 4 Form 4 — GV 2021, L.P. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — GV 2021 GP, L.L.C. View Filing
form 4 Form 4 — GV 2021 GP, L.L.C. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — GV 2019 GP, L.L.C. View Filing
form 4 Form 4 — GV 2019 GP, L.L.C. View Filing
form 4 Form 4 — Kucharski Brandt Walter View Filing
form 4 Form 4 — Kucharski Brandt Walter View Filing
form 4 Form 4 — Capozzi Christopher M. View Filing
form 4 Form 4 — Capozzi Christopher M. View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Wang Lingke View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — Colis Peter George View Filing
form 4 Form 4 — GV 2021 GP, L.L.C. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — GV 2021 GP, L.P. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — GV 2021 GP, L.L.C. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing
form 4 Form 4 — GV 2019 GP, L.L.C. View Filing
form 4 Form 4 — GV 2021, L.P. View Filing
form 4 Form 4 — GV 2021, L.P. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — GV 2021 GP, L.P. View Filing
form 4 Form 4 — GV 2019, L.P. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing
form 4 Form 4 — Alphabet Inc. View Filing
form 4 Form 4 — GV 2019 GP, L.P. View Filing